Present and future therapies of hepatitis B: From discovery to cure
about
Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog TherapyAdvances and Challenges in Studying Hepatitis B Virus In VitroSymbiotic chemo- and immuno-therapy for hepatitis B and C virusesA Convenient Truth: Cost of Medications Need Not Be a Barrier to Hepatitis B TreatmentEpidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.The Role of cccDNA in HBV Maintenance.Detection of HBV Covalently Closed Circular DNAHepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1.Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNAHuman induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virusEvolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.Control of Hepatitis B Virus by CytokinesProspects and progress of DNA vaccines for treating hepatitis B.Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.New therapies for chronic hepatitis B.Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators.Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor.Experimental models of hepatitis B and C - new insights and progressThe current status and future directions of hepatitis B antiviral drug discovery.Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics.Hepatitis A to E: what's new?New antivirals for the treatment of chronic hepatitis B.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities.A research agenda for curing chronic hepatitis B virus infection.Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.Epigenetic Regulation of Hepatitis B Virus Covalently Closed Circular DNA: Implications for Epigenetic Therapy against Chronic Hepatitis B.Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross-sectional survey.Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy.Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.[Vaccination against hepatitis B: success and challenges].New horizon for radical cure of chronic hepatitis B virus infection.Hepatitis B virus: is a cure possible?A Series of Oleanolic Acid Derivatives as Anti-Hepatitis B Virus Agents: Design, Synthesis, and in Vitro and in Vivo Biological Evaluation.Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitorsA potent human neutralizing antibody Fc-dependently reduces established HBV infections
P2860
Q26740161-30F88B57-8382-47AD-BBFB-84FFFE93F4BCQ26771134-B4EED0C0-A400-4AF2-9C70-E7343FF95152Q27468956-AF3FB81F-3A5A-4B4E-84F6-554EA331FE39Q28386440-ADAE298C-2C67-4182-B0F8-47FBF12C1E15Q30244568-C9E1B009-0859-4621-BE18-A8DF332A6360Q32182914-EC6515D1-4E3D-47E8-88C5-07B0423D6982Q32183310-5B98F701-C401-48B4-8A7A-85C71F63C872Q36241034-2DF63002-461A-4189-B1C0-0F401E5ACB46Q36343335-B716BDC1-D16A-4B09-8B54-D89396CCB898Q37076655-3A076E8A-92C5-4C71-9F30-4C6FEB50953EQ37540212-3E5C4A34-F83A-46B5-AC41-C0013DB5A160Q37628224-5B96C9B2-C191-486C-A9AE-3BFB9F16B029Q38664504-5F14782B-C016-45C1-AEE9-D98410D84E22Q38716558-0B361AE6-A3CB-43AF-96A1-1802E7B27713Q38725759-B5F53018-114C-4F5B-AF01-99A66D4587ABQ38755178-4DC3AB94-6776-4AC8-AA06-DEB9DFD9C076Q38770516-4B815043-130A-49EE-8B88-1FB46858657DQ38772524-5D01E465-9097-492F-99EA-84B454C06540Q38778496-44A036DD-5258-485B-84B7-C02A136729AFQ38802098-253284D2-1F93-4431-ABF0-3FF2B0A8D41BQ39136809-E353CE6D-132C-4C37-A595-1B5278E559D5Q39237214-7C0192A0-0C80-47C0-9190-53DF11ADAF09Q39315990-3404C497-5276-4FAE-ADBD-A3EE19D82B24Q39425755-C93EDCCC-4EC8-4C04-B205-A28C40330A6FQ39430042-FBA555E5-EF5E-4587-BAE0-B9D3C1A35DDEQ40055570-9ACAC5BC-9107-4C15-BECD-E2CCC266A1ABQ40066224-D44B62A3-D138-4060-918F-28AA41349F90Q40073818-E89FD020-0966-4209-B86D-73169CDCC98BQ40172897-2B6917BC-29B5-4D1C-BC24-CEEDDFA6F238Q40178518-F947F979-A726-46A0-8B28-3E6B9370FAA0Q40431628-4D1349FB-4C6D-4C81-9C13-2C38F790FDDDQ40476048-4385972F-D430-47E5-85B0-3E50A3A301E4Q40505022-C0D1C950-1696-4991-9FBD-2100882E31C7Q40533482-2467CC2D-1C85-40D5-A6FE-F210692C8590Q40544414-BF9D74CD-73D0-4474-B32B-DF5D0C3D8255Q40593364-C132E85B-F64D-49CF-96C4-85FDAC61F4C0Q40680454-25226F7D-3A97-4694-AD5B-85E4CAD263B6Q40737218-52637C5D-2DBE-4B92-A859-FFB1796F9A53Q40798098-7312C582-9A4E-434F-AC2B-E12B231A67B3Q41671765-8256FDFD-3D57-48BA-B944-60085E2F6BBF
P2860
Present and future therapies of hepatitis B: From discovery to cure
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Present and future therapies of hepatitis B: From discovery to cure
@ast
Present and future therapies of hepatitis B: From discovery to cure
@en
type
label
Present and future therapies of hepatitis B: From discovery to cure
@ast
Present and future therapies of hepatitis B: From discovery to cure
@en
prefLabel
Present and future therapies of hepatitis B: From discovery to cure
@ast
Present and future therapies of hepatitis B: From discovery to cure
@en
P2093
P2860
P356
P1433
P1476
Present and future therapies of hepatitis B: From discovery to cure
@en
P2093
Anna S Lok
Brian J McMahon
Ju-Tao Guo
Kyong-Mi Chang
Marc G Ghany
Stephan Urban
Stephen Locarnini
T Jake Liang
Timothy M Block
P2860
P304
P356
10.1002/HEP.28025
P407
P577
2015-10-27T00:00:00Z